KEVIN KILMURRAY: Open Payments
NPI 1437626181 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 29 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $427 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $202 |
| ABBVIE INC. | 9 | $157 |
| CVRx, Inc. | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| PFIZER INC. | 2 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Amgen Inc. | 1 | $14 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
Products named: LINQ II, BOTOX, Barostim Neo System, LEQVIO, JARDIANCE, ELIQUIS, AMVUTTRA, QULIPTA.
Industry payments across CA — which companies pay providers there.
